Sign In
Buy BBH
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
3 Gilead-Heavy ETFs To Watch Amid The AstraZeneca-Gilead Rumor
12:00am, Monday, 08'th Jun 2020
In the race to develop a coronavirus vaccine, AstraZeneca (NYSE: AZN) and Gilead Sciences (NASDAQ: GILD) are two of the leading contenders and that could be the starting point of...
These ETF Areas Make Great Investment Choices in June
08:55pm, Tuesday, 02'nd Jun 2020
Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.
Biotech ETFs to watch as companies push for coronavirus treatments
07:42pm, Monday, 18'th May 2020
Yahoo Finance's Seana Smith and ETF Trends CIO and Director Dave Nadig discuss the outlook on biotech ETFs as optimism grows over results for coronavirus treatments.
CAPROCK Group Inc. Buys New Shares in VanEck Vectors Biotech ETF (NASDAQ:BBH)
10:32am, Friday, 01'st May 2020
CAPROCK Group Inc. bought a new stake in VanEck Vectors Biotech ETF (NASDAQ:BBH) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The i
Biotech ETFs Gain on New Positive Data for Gilead's Remdesivir
08:50pm, Thursday, 30'th Apr 2020
As the coronavirus continues to spread, the latest positive data on remdesivir is some relief in such challenging times.
Healthcare ETFs to Gain on Progress in Coronavirus Vaccine
07:29pm, Wednesday, 29'th Apr 2020
The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.
Healthcare ETFs to Gain on Progress in Coronavirus Vaccine
12:00am, Wednesday, 29'th Apr 2020Ride Out the Coronavirus Mayhem With These ETF Areas
07:55pm, Friday, 24'th Apr 2020
We discuss some ETF areas that investors can choose to invest for a smoother sail during the coronavirus pandemic.
Ride Out the Coronavirus Mayhem With These ETF Areas
07:55pm, Friday, 24'th Apr 2020
We discuss some ETF areas that investors can choose to invest for a smoother sail during the coronavirus pandemic.
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners
06:30pm, Friday, 24'th Apr 2020
Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners
06:30pm, Friday, 24'th Apr 2020
Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.
This Stock Points to the Massive China Biotech Trend
09:00pm, Thursday, 23'rd Apr 2020
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case for the sector.
